Lantern Pharma Inc (LTRN) Unusual Options Activity Today

Checking LTRN unusual options activity helps you spot when traders are making outsized bets on Lantern Pharma Inc before the broader market catches on. Lantern Pharma Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor LTRN unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching LTRN unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking LTRN unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and LTRN unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways.

Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Catalysts rarely arrive without a footprint, and LTRN unusual options activity is often where that footprint shows up first. Our scanner tracks Lantern Pharma Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at LTRN unusual options volume on the call side or chasing put sweeps, Lantern Pharma Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.